Burnaby BC-based Xenon Pharmaceuticals Inc has entered into a strategic collaboration with the commercial arm of the Centre for Drug Research and Development (CDRD). Xenon will work with Drug Development Inc (DDI) to advance an early-stage R&D program. Xenon will leverage CDRD and DDI's technical and research strengths to reach certain early-stage R&D milestones and offers an opportunity to showcase DDI's ability to collaborate with the local life sciences and biotech industries. Xenon is a privately held company developing small molecule therapies targeting metabolic, neurological and cardiovascular diseases....